HK Stock Market Move | Fast selling (06288) resumes trading and rises nearly 10%, with a 19.6% year-on-year increase in mid-term net profit. Management raises expectations for the 2026 fiscal year.
Xunxiao (06288) resumed trading this morning with an increase of nearly 10%, as of the time of writing, it has increased by 9.76% to HK$36, with a turnover of HK$1.4448 million.
Xunxiao (06288) resumed trading this morning, rising nearly 10%. As of the time of writing, it had risen by 9.76% to HK$36, with a turnover of HK$144.48 million.
On the news front, Uniqlo's parent company, Xunxiao Group, announced its mid-year results as of the end of February this year. Total revenue for the first half of the fiscal year reached 2.0552 trillion yen, an increase of 14.8% year-on-year, with operating profit reaching 386.9 billion yen, an increase of 28.3% year-on-year, setting a record high for the first half of the year; net profit reached 279.2 billion yen, an increase of 19.6% year-on-year. In addition, due to better-than-expected performance in the first half, the management raised its expectations based on current sales trends, and updated its exchange rate assumptions due to the weakening of the yen. The revenue for the fiscal year 2026 is expected to be 3.9 trillion yen, originally planned at 3.8 trillion yen, representing a year-on-year increase of 14.7%. The operating profit is expected to reach 690 billion yen, originally planned at 650 billion yen, representing a year-on-year increase of 25.2%. Net profit attributable to owners of the company is expected to be 480 billion yen, originally planned at 450 billion yen, representing a year-on-year increase of 10.9%.
Related Articles

PATEO (02889) Signs Strategic Cooperation Framework Agreement with Shanghai Jiao Tong University to Drive Innovation Breakthroughs in the Field of Embodied Intelligence Based on Open Source HarmonyOS.

Zhida Technology (02650) has been included in the Hang Seng Composite Index and included in the list of stocks eligible for the Shenzhen-Hong Kong Stock Connect and Shanghai-Hong Kong Stock Connect.

SSY GROUP (02005): Obtain drug production registration approval for compound electrolyte sodium acetate glucose injection (250ml and 500ml) and metoclopramide hydrochloride injection (2ml:10mg).
PATEO (02889) Signs Strategic Cooperation Framework Agreement with Shanghai Jiao Tong University to Drive Innovation Breakthroughs in the Field of Embodied Intelligence Based on Open Source HarmonyOS.

Zhida Technology (02650) has been included in the Hang Seng Composite Index and included in the list of stocks eligible for the Shenzhen-Hong Kong Stock Connect and Shanghai-Hong Kong Stock Connect.

SSY GROUP (02005): Obtain drug production registration approval for compound electrolyte sodium acetate glucose injection (250ml and 500ml) and metoclopramide hydrochloride injection (2ml:10mg).

RECOMMEND





